These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 15577351

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Anti-CD40 ligand monoclonal antibody induces a permissive state, but not tolerance, for murine peripheral nerve allografts.
    Brenner MJ, Tung TH, Mackinnon SE, Myckatyn TM, Hunter DA, Mohanakumar T.
    Exp Neurol; 2004 Mar; 186(1):59-69. PubMed ID: 14980810
    [Abstract] [Full Text] [Related]

  • 4. Short-term anti-CD40 ligand costimulatory blockade induces tolerance to peripheral nerve allografts, resulting in improved skeletal muscle function.
    Brown DL, Bishop DK, Wood SY, Cederna PS.
    Plast Reconstr Surg; 2006 Jun; 117(7):2250-8. PubMed ID: 16772925
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term limb allograft survival using anti-CD40L antibody in a murine model.
    Tung TH, Mackinnon SE, Mohanakumar T.
    Transplantation; 2003 Mar 15; 75(5):644-50. PubMed ID: 12640303
    [Abstract] [Full Text] [Related]

  • 10. Immunosuppressive effect of monoclonal antibodies to ICAM-1 and LFA-1 on peripheral nerve allograft in mice.
    Nakao Y, Mackinnon SE, Strasberg SR, Hertl MC, Isobe M, Susskind BM, Mohanakumar T, Hunter DA.
    Microsurgery; 1995 Mar 15; 16(9):612-20. PubMed ID: 8747285
    [Abstract] [Full Text] [Related]

  • 11. Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody.
    Sun H, Subbotin V, Chen C, Aitouche A, Valdivia LA, Sayegh MH, Linsley PS, Fung JJ, Starzl TE, Rao AS.
    Transplantation; 1997 Dec 27; 64(12):1838-43. PubMed ID: 9422428
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Addition of Anti-CD40 Monoclonal Antibody to Nonmyeloablative Conditioning With Belatacept Abrogated Allograft Tolerance Despite Induction of Mixed Chimerism.
    Oura T, Hotta K, Rosales I, Dehnadi A, Kawai K, Lee H, Benedict Cosimi A, Kawai T.
    Transplantation; 2019 Jan 27; 103(1):168-176. PubMed ID: 30113996
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection.
    Metzler B, Gfeller P, Bigaud M, Li J, Wieczorek G, Heusser C, Lake P, Katopodis A.
    J Immunol; 2004 Dec 01; 173(11):7025-36. PubMed ID: 15557200
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fc-Silent Anti-CD154 Domain Antibody Effectively Prevents Nonhuman Primate Renal Allograft Rejection.
    Kim SC, Wakwe W, Higginbotham LB, Mathews DV, Breeden CP, Stephenson AC, Jenkins J, Strobert E, Price K, Price L, Kuhn R, Wang H, Yamniuk A, Suchard S, Farris AB, Pearson TC, Larsen CP, Ford ML, Suri A, Nadler S, Adams AB.
    Am J Transplant; 2017 May 01; 17(5):1182-1192. PubMed ID: 28097811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.